Literature DB >> 19002847

Inhibition effect of pcDNA-tum-5 on the growth of S180 tumor.

Yanjie You1, Xiaochang Xue, Meng Li, Xin Qin, Cun Zhang, Weihua Wang, Changli Giang, Shouzhen Wu, Yan Liu, Wenhua Zhu, Yonggang Ran, Zhen Zhang, Wei Han, Yingqi Zhang.   

Abstract

Tumor growth and metastasis depend on vessel formation, and inhibition of angiogenesis of tumor by production of anti-angiogenic drugs should be a promising approach for cancer therapy. Tumstatin is an angiogenesis inhibitor. The anti-angiogenic activity of tumstatin is localized to the 54-132 amino acids. The gene fragment encoding amino acids 45-132 of tumstatin (tum-5) was subcloned into pcDNA3.1 (pcDNA-tum5). Tum-5 protein could be expressed and secreted in CHO cells after transfection. The conditioned medium (containing tum-5 protein) from the transfectant has an anti-angiogenic effect on HUVEC cells in vitro. The anti-tumor effect of pcDNA-tum5 on mice bearing S180 tumors was evaluated. The results showed that pcDNA-tum-5 has a significant inhibition activity in the growth of the tumors. This study suggests that the gene delivery of tum-5 may be an effective strategy for cancer therapy.

Entities:  

Year:  2007        PMID: 19002847      PMCID: PMC2259260          DOI: 10.1007/s10616-007-9117-9

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  20 in total

1.  Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis.

Authors:  Y Maeshima; U L Yerramalla; M Dhanabal; K A Holthaus; S Barbashov; S Kharbanda; C Reimer; M Manfredi; W M Dickerson; R Kalluri
Journal:  J Biol Chem       Date:  2001-06-08       Impact factor: 5.157

2.  Effect of mid-late mouse fetus' microenvironment on the growth of tumor cells after intrauterine transplantation.

Authors:  Fang Ma; Lan Zhou; Liao-Qiong Fang; Jin Bai; Jie Zhao; Yuan Wang; Zhi-Biao Wang
Journal:  Cell Biol Int       Date:  2006-12-15       Impact factor: 3.612

3.  Antiangiogenic gene therapy.

Authors:  J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

Review 4.  Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy.

Authors:  J Denekamp
Journal:  Br J Radiol       Date:  1993-03       Impact factor: 3.039

5.  Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice.

Authors:  L A Lesoon-Wood; W H Kim; H K Kleinman; B D Weintraub; A J Mixson
Journal:  Hum Gene Ther       Date:  1995-04       Impact factor: 5.695

6.  Measurement of bovine IgG by indirect competitive ELISA as a means of detecting milk adulteration.

Authors:  I P Hurley; R C Coleman; H E Ireland; J H H Williams
Journal:  J Dairy Sci       Date:  2004-03       Impact factor: 4.034

Review 7.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

8.  Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization.

Authors:  E G Nabel; D Gordon; Z Y Yang; L Xu; H San; G E Plautz; B Y Wu; X Gao; L Huang; G J Nabel
Journal:  Hum Gene Ther       Date:  1992-12       Impact factor: 5.695

9.  Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate.

Authors:  C K Goldman; R L Kendall; G Cabrera; L Soroceanu; Y Heike; G Y Gillespie; G P Siegal; X Mao; A J Bett; W R Huckle; K A Thomas; D T Curiel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

Authors:  M S O'Reilly; L Holmgren; Y Shing; C Chen; R A Rosenthal; M Moses; W S Lane; Y Cao; E H Sage; J Folkman
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

View more
  7 in total

1.  Promoter hypermethylation contributes to the frequent suppression of the CDK10 gene in human nasopharyngeal carcinomas.

Authors:  Yanjie You; Wenjun Yang; Zhizhong Wang; Huimin Zhu; Haijun Li; Canfeng Lin; Yonggang Ran
Journal:  Cell Oncol (Dordr)       Date:  2013-06-06       Impact factor: 6.730

2.  Anti-cancer effects of celecoxib on nasopharyngeal carcinoma HNE-1 cells expressing COX-2 oncoprotein.

Authors:  Jiongyu Chen; Yonggang Ran; Chaoqun Hong; Zhijian Chen; Yanjie You
Journal:  Cytotechnology       Date:  2010-09-01       Impact factor: 2.058

3.  Vector-mediated Tum-5 expression in neovascular endothelial cells for treating hepatocellular carcinoma.

Authors:  Chun Li; Xingang Guan; Boqian Sun; Mingyao Ma; Peng Wang; Xiaodong Gai
Journal:  Exp Ther Med       Date:  2017-02-15       Impact factor: 2.447

4.  Cloning and expression of the tumstatin active peptides-T(7) and its derivant-T(7)-NGR.

Authors:  Song Naling; He Xin; Zhao Qiren; Yan Tingdong; Wen Lei
Journal:  Clin Exp Med       Date:  2009-02-03       Impact factor: 3.984

5.  The enhancement of radiosensitivity in human esophageal squamous cell carcinoma cells by zoledronic acid and its potential mechanism.

Authors:  Yanjie You; Jianfeng Liu; Zhizhong Wang; Yuan Zhang; Yonggang Ran; Xu Guo; Huimin Liu; Haibo Wang
Journal:  Cytotechnology       Date:  2013-01-19       Impact factor: 2.058

Review 6.  Tumor angiogenesis and anti-angiogenic gene therapy for cancer.

Authors:  Tinglu Li; Guangbo Kang; Tingyue Wang; He Huang
Journal:  Oncol Lett       Date:  2018-05-17       Impact factor: 2.967

7.  Escherichia coli Nissle 1917 engineered to express Tum-5 can restrain murine melanoma growth.

Authors:  Lian He; Huijun Yang; Fei Liu; Yiyan Chen; Sijia Tang; Wei Ji; Jianli Tang; Zhudong Liu; Yunjun Sun; Shengbiao Hu; Youming Zhang; Xiong Liu; Weitao Huang; Xuezhi Ding; Liqiu Xia
Journal:  Oncotarget       Date:  2017-08-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.